← Leaderboards

Michelle Christina Odden

Oregon State University

Google Scholar ↗PubMed ↗ORCID ↗

$11,202,287

Attributed

$18,025,746

Total exposure

14

Grants

6

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.3M · FY2012–25

$5M$3.8M$2.5M$1.3M$0

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$18,025,746 · 14

By mechanism

R01$11,143,742 · 7

RF1$3,327,236 · 1

R56$1,296,920 · 2

R25$1,186,785 · 1

K01$687,660 · 1

R21$220,500 · 1

Top collaborators

Most similar at Oregon State University

Same institution · by research overlap

Kelly K Falkner$630,631
Kari B O'Connell$3,219,463

Others in their field

Top investigators on “Event”

Everette D Joseph · Howard University$250,079,293
Valerie Koch · University Corporation For Atmospheric Res$247,762,266
Eric J Barron · Pennsylvania State Univ University Park$243,972,016
Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
Francis L Halzen · University Of Wisconsin-Madison$229,314,069

Research focus

EventCardiovascular DiseasesCardiovascular SystemParticipantElderlyAdultStrokePersonsAgingRisk FactorsAlzheimer&AposImpaired CognitionHypertensionMortalityLinkCohortBlood PressurePrevalenceCognitiveUnited States National Institutes Of HealthPharmaceutical PreparationsDesignDementiaCardiovascular Disorder Risk

Grant awards (36)

Infrastructure for mentored access to CHS data and specimens$1,372,795

R01 · FY2025 · HL

Proteomic profiling to identify mechanisms of susceptibility and resilience to cardiac dysfunction in Black Americans$815,229

R01 · FY2025 · HL

Illuminating our understanding of statins and Alzheimers Disease and Dementia using modern causal inference methods$784,514

R01 · FY2025 · AG

Deprescribing Cardiovascular Medications among Persons with and without Alzheimer's Disease and Related Dementias in Long-Term Care$677,931

R01 · FY2025 · AG

Population Health Aging Research - Advancing Health Equity and Diversity (PHAR-AHEaD)$394,875

R25 · FY2025 · AG · contact PI

Stanford BSSR Pre-Doctoral Training Program at the Intersection of Data Sciences with Behavioral, Social, and Population Health Research$162,903

T32 · FY2025 · HL

Deprescribing Cardiovascular Medications among Persons with and without Alzheimer's Disease and Related Dementias in Long-Term Care$59,879

R01 · FY2025 · AG · contact PI

Deprescribing Cardiovascular Medications among Persons with and without Alzheimer's Disease and Related Dementias in Long-Term Care$35,927

R01 · FY2025 · AG

Illuminating our understanding of statins and Alzheimers Disease and Dementia using modern causal inference methods$839,767

R01 · FY2024 · AG

Deprescribing Cardiovascular Medications among Persons with and without Alzheimer's Disease and Related Dementias in Long-Term Care$727,688

R01 · FY2024 · AG · contact PI

Mitochondrial health, cardiovascular risk, and blood pressure targets in hypertensive adults$663,944

R01 · FY2024 · HL

Population Health Aging Research - Advancing Health Equity and Diversity (PHAR-AHEaD)$394,875

R25 · FY2024 · AG · contact PI

Mitochondrial health, cardiovascular risk, and blood pressure targets in hypertensive adults$702,817

R01 · FY2023 · HL

Population Health Aging Research - Advancing Health Equity and Diversity (PHAR-AHEaD)$397,035

R25 · FY2023 · AG · contact PI

Cardiovascular and Cerebrovascular Risk Factors for Mobility Limitation in the Jackson Heart Study$389,984

R01 · FY2023 · AG · contact PI

Mitochondrial health, cardiovascular risk, and blood pressure targets in hypertensive adults$714,354

R01 · FY2022 · HL

Cardiovascular and Cerebrovascular Risk Factors for Mobility Limitation in the Jackson Heart Study$389,961

R01 · FY2022 · AG · contact PI

Mitochondrial health, cardiovascular risk, and blood pressure targets in hypertensive adults$757,768

R01 · FY2021 · HL

Cardiovascular and Cerebrovascular Risk Factors for Mobility Limitation in the Jackson Heart Study$389,265

R01 · FY2021 · AG · contact PI

Cardiovascular and Cerebrovascular Risk Factors for Mobility Limitation in the Jackson Heart Study$403,717

R01 · FY2020 · AG · contact PI

Management of Hypertension among Persons with and without Dementia in Long-Term Care$3,327,236

RF1 · FY2019 · AG · contact PI

Statins and Risk of Alzheimer's Disease and Related Dementias: A Novel Quasi- Experimental Approach to Identify Causal Effects$705,777

R56 · FY2019 · AG

Prevalence and Prognosis of Blood Pressure Medication Deintensification among Older VA Nursing Home Residents$591,143

R56 · FY2018 · AG

A New Paradigm for Hypertension in the Elderly- Beyond Age$312,569

R01 · FY2018 · AG

Preservation of Vascular and Functional Health Among Nonagenarians$89,060

R21 · FY2018 · HL · contact PI

Preservation of Vascular and Functional Health Among Nonagenarians$21,190

R21 · FY2018 · HL · contact PI

A New Paradigm for Hypertension in the Elderly- Beyond Age$318,832

R01 · FY2017 · AG

A New Paradigm for Hypertension in the Elderly- Beyond Age$163,148

R01 · FY2017 · AG

Preservation of Vascular and Functional Health Among Nonagenarians$110,250

R21 · FY2017 · HL · contact PI

A New Paradigm for Hypertension in the Elderly- Beyond Age$309,383

R01 · FY2016 · AG

Modeling Optimal Strategies to Prevent Cardiovascular Events in Older Adults$137,532

K01 · FY2016 · AG · contact PI

Modeling Optimal Strategies to Prevent Cardiovascular Events in Older Adults$137,532

K01 · FY2015 · AG · contact PI

A New Paradigm for Hypertension in the Elderly- Beyond Age$314,270

R01 · FY2014 · AG

Modeling Optimal Strategies to Prevent Cardiovascular Events in Older Adults$137,532

K01 · FY2014 · AG · contact PI

Modeling Optimal Strategies to Prevent Cardiovascular Events in Older Adults$137,532

K01 · FY2013 · AG · contact PI

Modeling Optimal Strategies to Prevent Cardiovascular Events in Older Adults$137,532

K01 · FY2012 · AG · contact PI